Product Manual

Page 1 of 12
FOR INFORMATIONAL USE ONLY
FOR INFORMATIONAL USE ONLY
Not to be used for performing assay. Refer to most current package insert accompanying your test kit.
QuickVue iFOB TEST
CLIA Complexity: WAIVED
INTENDED USE
The QuickVue iFOB (immunochemical Fecal Occult Blood) test is an immunochemical
device intended for the qualitative detection of fecal occult blood by laboratories or
physiciansoffices. It is useful in determining gastrointestinal (GI) bleeding found in a
number of gastrointestinal disorders, such as: diverticulitis, colitis, polyps, and colorectal
cancer. This test is recommended for use in: (1) routine physical examinations or when
hospital patients are first admitted, (2) hospital monitoring for GI bleeding in patients,
and (3) screening for colorectal cancer or gastrointestinal bleeding from any source.
SUMMARY AND EXPLANATION
The American Cancer Society and Centers for Disease Control recommend a fecal occult
blood test annually after age 50 to aid in the early detection of colorectal cancer.
1
The Guaiac test is widely available but lacks high accuracy. Guaiac is a naturally
occurring phenolic compound that can be oxidized to quinone by hydrogen
peroxidases with a detectable color change. The sensitivity and specificity of Guaiac
tests are much lower than those of Immunochemical assays. The low accuracy of
the Guaiac dye method is related to dietary peroxidases, including hemoglobin and
myoglobin from meat and uncooked fruits and vegetables. Additionally, iron intake
may cause false positive results with Guaiac tests.
2
The QuickVue iFOB test is much more sensitive and has been designed to be
more specific in detecting low levels of human fecal occult blood. It is highly
accurate compared to the Guaiac method. The results of immunochemical FOB
rapid tests are not affected by dietary peroxidases, animal blood or ascorbic acid. A
Japanese study demonstrated using immunochemical FOB tests reduced colorectal
cancer-related mortality by 60%.
3

Summary of content (12 pages)